Kkc Lee

Kkc Lee

Auto-generated profile, based on publicly available information

Kkc Lee

School of Medicine, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Malaysia

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2010 in Journal of Cardiovascular Pharmacology and Therapeutics
Verified
Journal Article
Closed access
JCJennifer S. T. Chung
Jennifer S. T. Chung
KLKenneth K. C. Lee
Kenneth K. C. Lee
Brian TomlinsonBrian Tomlinson
Brian Tomlinson
VLVivian WY Lee
Vivian WY Lee
Objective: To assess the clinical and economic outcomes of a clinical pharmacy service (CPS) in dyslipidemic management. Method: This was a 24-month prospective controlled trial conducted at the lipid clinic of a public hospital in Hong Kong. In the intervention group, a clinical pharmacist assessed low-density lipoprotein cholesterol (LDL-C) levels and provided recommendations in accordance to the Adult Treatment Panel III (ATP III) guidelines. Medication compliance and the proper use of drugs were assessed. Education on healthy lifestyles was reinforced. Monthly telephone follow-ups were made to check on the progress of patients. In the control group, patients received usual medical care with no pharmacist intervention. Primary outcome was the percentage of patients achieving the ATP III LDL-C goal at the end of study. The estimated cost of such service was also evaluated. Results: A total of 300 patients were recruited into the study (150 in intervention group and 150 in control group). In the intervention group, 58.7% patients achieved LDL-C goals compared with 45.3% in the control group (P < .05). The intervention group achieved 26.4%, 17.4%, and 30.0% mean reduction in LDL-C, total cholesterol (TC), and triglycerides (TG) levels, respectively, compared with 12.6%, 6.6%, and 11.5% in the control group (P < .05). The estimated cost for this clinical service was US$385/month for a total of 600 dyslipidemic patients seen per year. Conclusion: The results of this study demonstrate the positive impact CPS can have on achieving treatment goals in lipid management. Similar services for other problematic conditions such as hypertension and diabetes mellitus may also be benefited by similar CPSs.

1 January 2008 in American Journal of Cardiovascular Drugs
Verified
Journal Article
Closed access
PDF file
VLVivian WY Lee
Vivian WY Lee
IHIvan C. H. Ho
Ivan C. H. Ho
WCWindy S. Y. Chan
Windy S. Y. Chan
KTKai Yin Tam
Kai Yin Tam
KLKenneth K. C. Lee
Kenneth K. C. Lee

1 November 2006
Verified
Journal Article
Closed access
Kam Lun Ellis HonKam Lun Ellis Hon
Kam Lun Ellis Hon
VLVivian WY Lee
Vivian WY Lee
Ting Fan LeungTing Fan Leung
Ting Fan Leung
KLKenneth K C Lee
Kenneth K C Lee
ACAndrew K W Chan
Andrew K W Chan
PLPing-Chung Leung
Ping-Chung Leung

1 July 2012
Verified
Journal Article
Closed access
Kam Lun Ellis HonKam Lun Ellis Hon
Kam Lun Ellis Hon
SWShuxin Susan Wang
Shuxin Susan Wang
KLKenneth K C Lee
Kenneth K C Lee
VLVivian WY Lee
Vivian WY Lee
Ting Fan LeungTing Fan Leung
Ting Fan Leung
MIMargaret Ip
Margaret Ip

14 January 2019 in Journal of Medical Economics
Verified
Journal Article
Closed access
JCJune W. Y. Choon
June W. Y. Choon
DWDavid B. C. Wu
David B. C. Wu
HCH. Y. Chong
H. Y. Chong
WLWilliam T. L. Lo
William T. L. Lo
CCCatherine S. Y. Chong
Catherine S. Y. Chong
KLKenneth K. C. Lee
Kenneth K. C. Lee
Background: Very few data are available to demonstrate the economic benefit of early paliperidone palmitate once-monthly long-acting injectable (PP1M) treatment in patients with schizophrenia or schizoaffective disorder. Methods and materials: We have retrospectively compared the health care utilization and associated costs of pre and post PPIM treatment in 413 patients with schizophrenia or schizoaffective disorder recruited from 3 major public hospitals providing psychiatric services in Hong Kong. Patients were categorized into early treatment (< =3yrs since diagnosis) and chronic (>3yrs) groups, and also whether they were receiving polypharmacy (POP). Results: We found that patients who were started on early therapy with no POP had the most favourable outcomes. Overall results of the entire cohort including both early and late treatments indicate that there was a slight increase in annual in-patient days (IP) per patient and outpatient visit (OP) by 3.18 and 1.87 respectively, and a decrease in emergency room visit (ER) of 0.9 (p < 0.05). For non-polypharmacy (NP) patients receiving early PP1M therapy, there was a significant decrease in IP and ER of 21.56 (p < 0.05) and 1.15 (p < 0.05), respectively, but an increase in OP of 1.88 (p < 0.05). For patients with POP, there was an all-across increase in IP and all-across decrease in OP and ER. In monetary terms, a NP patient receiving early therapy may have an overall savings of HKD40,878 (USD5,241, 1USD =7.8HKD) per year compared to HKD6,224 (USD798) in patients where therapy was given after 3 years. For patients with POP, there was an all-across increase in overall spending despite reductions in OP and ER. Conclusions: From the 413 patients studied, potential annual savings is higher by early administration of PPIM in patients with NP. Analysis using multivariate linear regression based on generalized estimating equations and sensitivity analysis using linear mixed model supported the findings.

6 June 2018 in JMIR Research Protocols
Verified
Journal Article
Open access
NANiekla Survia Andiesta
Niekla Survia Andiesta
MHMaimunah A Hamid
Maimunah A Hamid
KLKkc Lee
Kkc Lee
APAllan Pau
Allan Pau
Background: In 2012, nearly 4000 children in Malaysia were referred to hospital pediatric dental services due to dental caries. Recent research has reported the effectiveness of dental home visits in preventing caries development in young children. Dental home visits (DHVs) are described as an ongoing relationship between the dentist and their patients, providing all aspects of a preventive oral health care program in the presence of the parents at home. Objective: The objective of this study is to evaluate the cost-effectiveness of dental home visits and oral health information, in the form of educational leaflets, in preventing new caries development in young children, compared to those receiving only educational leaflets over a period of two years. Cost-effectiveness analysis will be used to evaluate the cost-effectiveness of dental home visits. Methods: This is a collaborative project with the Oral Health Division of the Ministry of Health Malaysia. The Oral Health Division will provide access to a subsample from the National Oral Health of Preschoolers Survey which was carried out in 2015. The population of interest is children aged 5 and 6 years from kindergartens in the Selangor state of Malaysia. The study adopted a societal perspective for cost-effectiveness analysis and all types of resources that are of value to society will be included in analyzing the costs; such as cost to the patient, cost to the provider or institution, and indirect costs because of loss of productivity. Results: The trial has been approved by the International Medical University Malaysia's Joint Research and Ethics Committee (Project ID: IMU R157-2014 [File III-2016]). This trial is currently recruiting participants. Conclusions: The number of young children in Malaysia who have been referred to the hospital children's dentistry service for severe caries is disturbing. The cost of dental treatment in young children is high due to the severity of the caries which require an aggressive treatment, and the need for general anesthesia or sedation. This study will provide information on the cost and effectiveness of DHVs in caries prevention of young children in Malaysia.